(Q64222876)
Statements
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis (English)
0 references
June 2014
0 references
February 2015
0 references
94
0 references
10 year
0 references
70 year
0 references